8037 — China Biotech Services Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for China Biotech Services Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	386	152	92.8	72.1	18.9
Net Total Accounts Receivable
Net Total Receivables	46.2	108	761	35.9	25.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	446	278	885	261	63.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	148	105	129	124	235
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	904	707	1,470	662	530
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	272	227	549	159	193
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	561	311	868	200	265
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	343	395	603	463	265
Total Liabilities & Shareholders' Equity	904	707	1,470	662	530
Total Common Shares Outstanding